- 24 November, 2024
Jim Cramer: IBM stock is a buy following strong Q1 results
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Procter and Gamble Q3 results: CEO says company is focused on long-term value creation
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Carvana stock price forecast ahead of earnings
The Carvana (NYSE: CVNA) stock price is crawling back as investors focus on the upcoming quarterly results. The shares are trading at $101.77, which is
US stocks close higher, Netflix shares plunge 25% after hours – Market update
US stocks traded higher on Tuesday after a slow start to the week, with all the major indexes closing higher. The S&P 500 edged 1.6%
Netflix tanks 25% on Q1 results: it’s a warning for streaming services
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Is a 75 bps increase in interest rate on the cards?
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Lockheed misses on Q1 revenue: CEO expects the hit to be temporary
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
This athletic apparel retailer has momentum beyond the pandemic
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Netflix Q1 earnings preview: this quarter could be really messy
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Here is why Natus Medical is up 25%
Natus Medical Incorporated (NASDAQ: NTUS) shares are up 25% after the medical device solutions provider for screening, diagnosing and treating disorders that affect the brain